-
2
-
-
78049485263
-
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
-
Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127:2893-2917.
-
(2010)
Int J Cancer
, vol.127
, pp. 2893-2917
-
-
Ferlay, J.1
Shin, H.R.2
Bray, F.3
-
3
-
-
84898543637
-
Overdetection in screening for prostate cancer
-
Hugosson J, Carlsson S. Overdetection in screening for prostate cancer. Curr Opin Urol 2014; 24:256-263.
-
(2014)
Curr Opin Urol
, vol.24
, pp. 256-263
-
-
Hugosson, J.1
Carlsson, S.2
-
5
-
-
84919871373
-
Screening and prostate cancer mortality: Results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
-
Schroder FH, Hugosson J, Roobol MJ, et al. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet 2014; 384:2027-2035.
-
(2014)
Lancet
, vol.384
, pp. 2027-2035
-
-
Schroder, F.H.1
Hugosson, J.2
Roobol, M.J.3
-
6
-
-
84864008031
-
Radical prostatectomy versus observation for localized prostate cancer
-
Wilt TJ, Brawer MK, Jones KM, et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 2012; 367:203-213.
-
(2012)
N Engl J Med
, vol.367
, pp. 203-213
-
-
Wilt, T.J.1
Brawer, M.K.2
Jones, K.M.3
-
7
-
-
4644233846
-
Localized prostate cancer: Quality of life meets Whitmore's legacy
-
Bermejo C, Kristal AR, Zeliadt SB, et al. Localized prostate cancer: quality of life meets Whitmore's legacy. J Natl Cancer Inst 2004; 96:1348-1349.
-
(2004)
J Natl Cancer Inst
, vol.96
, pp. 1348-1349
-
-
Bermejo, C.1
Kristal, A.R.2
Zeliadt, S.B.3
-
8
-
-
84898543801
-
The role of focal therapy in the management of localised prostate cancer: A systematic review
-
Valerio M, Ahmed HU, Emberton M, et al. The role of focal therapy in the management of localised prostate cancer: A systematic review. Eur Urol 2014; 66:732-751.
-
(2014)
Eur Urol
, vol.66
, pp. 732-751
-
-
Valerio, M.1
Ahmed, H.U.2
Emberton, M.3
-
9
-
-
84914170524
-
Low-Risk and Very-Low-Risk Prostate Cancer: Is there a Role for Focal Therapy in the Era of Active Surveillance? Yes the the two approaches complement each other
-
Klotz L, Polascik TJ. Low-Risk and Very-Low-Risk Prostate Cancer: Is there a Role for Focal Therapy in the Era of Active Surveillance? Yes the the two approaches complement each other. Oncology 2014; 28:950.
-
(2014)
Oncology
, vol.28
, pp. 950
-
-
Klotz, L.1
Polascik, T.J.2
-
10
-
-
73949130115
-
Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer
-
Klotz L, Zhang L, Lam A, et al. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 2010; 28:126-131.
-
(2010)
J Clin Oncol
, vol.28
, pp. 126-131
-
-
Klotz, L.1
Zhang, L.2
Lam, A.3
-
11
-
-
84868563896
-
Active surveillance for prostate cancer: A systematic review of the literature
-
Dall'Era MA, Albertsen PC, Bangma C, et al. Active surveillance for prostate cancer: A systematic review of the literature. Eur Urol 2012; 62:976-983.
-
(2012)
Eur Urol
, vol.62
, pp. 976-983
-
-
Dall'era, M.A.1
Albertsen, P.C.2
Bangma, C.3
-
12
-
-
79957957477
-
Active surveillance program for prostate cancer: An update of the Johns Hopkins experience
-
Tosoian JJ, Trock BJ, Landis P, et al. Active surveillance program for prostate cancer: An update of the Johns Hopkins experience. J Clin Oncol 2011; 29:2185-2190.
-
(2011)
J Clin Oncol
, vol.29
, pp. 2185-2190
-
-
Tosoian, J.J.1
Trock, B.J.2
Landis, P.3
-
13
-
-
79960240491
-
Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance
-
Porten SP, Whitson JM, Cowan JE, et al. Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance. J Clin Oncol 2011; 29:2795-2800.
-
(2011)
J Clin Oncol
, vol.29
, pp. 2795-2800
-
-
Porten, S.P.1
Whitson, J.M.2
Cowan, J.E.3
-
14
-
-
53249155905
-
Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance
-
Berglund RK, Masterson TA, Vora KC, et al. Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance. J Urol 2008; 180:1964-1967.
-
(2008)
J Urol
, vol.180
, pp. 1964-1967
-
-
Berglund, R.K.1
Masterson, T.A.2
Vora, K.C.3
-
15
-
-
83955162939
-
Predictors of unfavourable repeat biopsy results in men participating in a prospective active surveillance program
-
Bul M, van den Bergh RCN, Rannikko A, et al. Predictors of unfavourable repeat biopsy results in men participating in a prospective active surveillance program. Eur Urol 2012; 61:370-377.
-
(2012)
Eur Urol
, vol.61
, pp. 370-377
-
-
Bul, M.1
Van Den Bergh, R.C.N.2
Rannikko, A.3
-
16
-
-
34547670085
-
Predictors of histological disease progression in untreated, localized prostate cancer
-
Venkitaraman R, Norman A, Woode-Amissah R, et al. Predictors of histological disease progression in untreated, localized prostate cancer. J Urol 2007; 178:833-837.
-
(2007)
J Urol
, vol.178
, pp. 833-837
-
-
Venkitaraman, R.1
Norman, A.2
Woode-Amissah, R.3
-
17
-
-
78049478880
-
Careful selection and close monitoring of low-risk prostate cancer patients on active surveillance minimizes the need for treatment
-
Soloway MS, Soloway CT, Eldefrawy A, et al. Careful selection and close monitoring of low-risk prostate cancer patients on active surveillance minimizes the need for treatment. Eur Urol 2010; 58:831-835.
-
(2010)
Eur Urol
, vol.58
, pp. 831-835
-
-
Soloway, M.S.1
Soloway, C.T.2
Eldefrawy, A.3
-
18
-
-
84880306415
-
Association between percentage of tumor involvement and Gleason score upgrading in low-risk prostate cancer
-
(Northwood, London, England)
-
Fu Q, Moul JW, Banez LL, et al. Association between percentage of tumor involvement and Gleason score upgrading in low-risk prostate cancer. Med Oncol (Northwood, London, England) 2012; 29:3339-3344.
-
(2012)
Med Oncol
, vol.29
, pp. 3339-3344
-
-
Fu, Q.1
Moul, J.W.2
Banez, L.L.3
-
19
-
-
77952876424
-
The Epstein criteria predict for organconfined but not insignificant disease and a high likelihood of cure at radical prostatectomy
-
Lee MC, Dong F, Stephenson AJ, et al. The Epstein criteria predict for organconfined but not insignificant disease and a high likelihood of cure at radical prostatectomy. Eur Urol 2010; 58:90-95.
-
(2010)
Eur Urol
, vol.58
, pp. 90-95
-
-
Lee, M.C.1
Dong, F.2
Stephenson, A.J.3
-
20
-
-
84872963407
-
Delayed radical prostatectomy for intermediate-risk prostate cancer is associated with biochemical recurrence: Possible implications for active surveillance from the SEARCH database
-
Abern MR, Aronson WJ, Terris MK, et al. Delayed radical prostatectomy for intermediate-risk prostate cancer is associated with biochemical recurrence: possible implications for active surveillance from the SEARCH database. The Prostate 2013; 73:409-417.
-
(2013)
The Prostate
, vol.73
, pp. 409-417
-
-
Abern, M.R.1
Aronson, W.J.2
Terris, M.K.3
-
21
-
-
84911987418
-
Characteristics and experiences of patients with localized prostate cancer who left an active surveillance program
-
Berger ZD, Yeh JC, Carter HB, Pollack CE. Characteristics and experiences of patients with localized prostate cancer who left an active surveillance program. The Patient 2014; 7:427-436.
-
(2014)
The Patient
, vol.7
, pp. 427-436
-
-
Berger, Z.D.1
Yeh, J.C.2
Carter, H.B.3
Pollack, C.E.4
-
22
-
-
84929302920
-
A longitudinal study on the impact of active surveillance for prostate cancer on anxiety and distress levels
-
[Epub ahead of print]
-
Venderbos LDF., van den Bergh RCN., Roobol MJ, et al. A longitudinal study on the impact of active surveillance for prostate cancer on anxiety and distress levels. Psycho-Oncology 2014. [Epub ahead of print]. doi: 10.1002/pon. 3657.
-
(2014)
Psycho-Oncology
-
-
Venderbos, L.D.F.1
Van Den Bergh, R.C.N.2
Roobol, M.J.3
-
23
-
-
69249119890
-
Anxiety and distress during active surveillance for early prostate cancer
-
van den Bergh RC, Essink-Bot ML, Roobol MJ, et al. Anxiety and distress during active surveillance for early prostate cancer. Cancer 2009; 115:3868-3878.
-
(2009)
Cancer
, vol.115
, pp. 3868-3878
-
-
Van Den Bergh, R.C.1
Essink-Bot, M.L.2
Roobol, M.J.3
-
24
-
-
41149115801
-
Staging saturation biopsy in patients with prostate cancer on active surveillance protocol
-
Abouassaly R, Lane BR, Jones JS. Staging saturation biopsy in patients with prostate cancer on active surveillance protocol. Urology 2008; 71:573-577.
-
(2008)
Urology
, vol.71
, pp. 573-577
-
-
Abouassaly, R.1
Lane, B.R.2
Jones, J.S.3
-
25
-
-
70350443250
-
Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails
-
Duffield AS, Lee TK, Miyamoto H, et al. Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails. J Urol 2009; 182:2274-2278.
-
(2009)
J Urol
, vol.182
, pp. 2274-2278
-
-
Duffield, A.S.1
Lee, T.K.2
Miyamoto, H.3
-
26
-
-
84879556419
-
Short-term functional outcomes and complications associated with transperineal template prostate mapping biopsy
-
Tsivian M, Abern MR, Qi P, Polascik TJ. Short-term functional outcomes and complications associated with transperineal template prostate mapping biopsy. Urology 2013; 82:166-170.
-
(2013)
Urology
, vol.82
, pp. 166-170
-
-
Tsivian, M.1
Abern, M.R.2
Qi, P.3
Polascik, T.J.4
-
27
-
-
84876294696
-
Clinical-pathologic correlation between transperineal mapping biopsies of the prostate and three-dimensional reconstruction of prostatectomy specimens
-
Crawford ED, Rove KO, Barqawi AB, et al. Clinical-pathologic correlation between transperineal mapping biopsies of the prostate and three-dimensional reconstruction of prostatectomy specimens. The Prostate 2013; 73:778-787.
-
(2013)
The Prostate
, vol.73
, pp. 778-787
-
-
Crawford, E.D.1
Rove, K.O.2
Barqawi, A.B.3
-
28
-
-
43949119459
-
The morbidity of transperineal template-guided prostate mapping biopsy
-
Merrick GS, Taubenslag W, Andreini H, et al. The morbidity of transperineal template-guided prostate mapping biopsy. BJU Int 2008; 101:1524-1529.
-
(2008)
BJU Int
, vol.101
, pp. 1524-1529
-
-
Merrick, G.S.1
Taubenslag, W.2
Andreini, H.3
-
29
-
-
84883184816
-
Multiparametric MR imaging for detection of clinically significant prostate cancer: A validation cohort study with transperineal template prostate mapping as the reference standard
-
Arumainayagam N, Ahmed HU, Moore CM, et al. Multiparametric MR imaging for detection of clinically significant prostate cancer: A validation cohort study with transperineal template prostate mapping as the reference standard. Radiology 2013; 268:761-769.
-
(2013)
Radiology
, vol.268
, pp. 761-769
-
-
Arumainayagam, N.1
Ahmed, H.U.2
Moore, C.M.3
-
30
-
-
84861096940
-
Prostate cancer foci detected on multiparametric magnetic resonance imaging are histologically distinct from those not detected
-
Rosenkrantz AB, Mendrinos S, Babb JS, Taneja SS. Prostate cancer foci detected on multiparametric magnetic resonance imaging are histologically distinct from those not detected. J Urol 2012; 187:2032-2038.
-
(2012)
J Urol
, vol.187
, pp. 2032-2038
-
-
Rosenkrantz, A.B.1
Mendrinos, S.2
Babb, J.S.3
Taneja, S.S.4
-
32
-
-
84925947273
-
Comparing 3-T multiparametric MRI and the Partin tables to predict organ-confined prostate cancer after radical prostatectomy
-
Gupta RT, Faridi KF, Singh AA, et al. Comparing 3-T multiparametric MRI and the Partin tables to predict organ-confined prostate cancer after radical prostatectomy. Urol Oncol 2014; 32:1292-1299.
-
(2014)
Urol Oncol
, vol.32
, pp. 1292-1299
-
-
Gupta, R.T.1
Faridi, K.F.2
Singh, A.A.3
-
33
-
-
84871242251
-
MRI-ultrasound fusion for guidance of targeted prostate biopsy
-
Marks L, Young S, Natarajan S. MRI-ultrasound fusion for guidance of targeted prostate biopsy. Curr Opin Urol 2013; 23:43-50.
-
(2013)
Curr Opin Urol
, vol.23
, pp. 43-50
-
-
Marks, L.1
Young, S.2
Natarajan, S.3
-
34
-
-
84898539555
-
A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: The PROFUS trial
-
Wysock JS, Rosenkrantz AB, Huang WC, et al. A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial. Eur Urol 2014; 66:343-351.
-
(2014)
Eur Urol
, vol.66
, pp. 343-351
-
-
Wysock, J.S.1
Rosenkrantz, A.B.2
Huang, W.C.3
-
35
-
-
84870489591
-
Image-guided prostate biopsy using magnetic resonance imaging-derived targets: A systematic review
-
Moore CM, Robertson NL, Arsanious N, et al. Image-guided prostate biopsy using magnetic resonance imaging-derived targets: A systematic review. Eur Urol 2013; 63:125-140.
-
(2013)
Eur Urol
, vol.63
, pp. 125-140
-
-
Moore, C.M.1
Robertson, N.L.2
Arsanious, N.3
-
36
-
-
84904987996
-
The role of MRI-targeted and confirmatory biopsies for cancer upstaging at selection in patients considered for active surveillance for clinically low-risk prostate cancer
-
Marliere F, Puech P, Benkirane A, et al. The role of MRI-targeted and confirmatory biopsies for cancer upstaging at selection in patients considered for active surveillance for clinically low-risk prostate cancer. World J Urol 2014; 32:951-958.
-
(2014)
World J Urol
, vol.32
, pp. 951-958
-
-
Marliere, F.1
Puech, P.2
Benkirane, A.3
-
37
-
-
84928543098
-
V6-06 use of MRI/US fusion for targeted prostate biopsy in active surveillance
-
Le J, Filson C, Margolis D, Marks L. V6-06 Use of MRI/US Fusion for Targeted Prostate Biopsy in Active Surveillance. The Journal of Urology. 2014;191(4S):e679.
-
(2014)
The Journal of Urology
, vol.191
, Issue.4 S
, pp. e679
-
-
Le, J.1
Filson, C.2
Margolis, D.3
Marks, L.4
-
38
-
-
84919778618
-
Transperineal in-bore 3-T MR imaging-guided prostate biopsy: A prospective clinical observational study
-
Penzkofer T, Tuncali K, Fedorov A, et al. Transperineal in-bore 3-T MR imaging-guided prostate biopsy: A prospective clinical observational study. Radiology 2015; 274:170-180.
-
(2015)
Radiology
, vol.274
, pp. 170-180
-
-
Penzkofer, T.1
Tuncali, K.2
Fedorov, A.3
-
39
-
-
84902079840
-
Targeted prostate biopsies: The complexity behind a simple concept
-
Passoni NM, Polascik TJ. Targeted prostate biopsies: the complexity behind a simple concept. Eur Urol 2014; 66:30-31.
-
(2014)
Eur Urol
, vol.66
, pp. 30-31
-
-
Passoni, N.M.1
Polascik, T.J.2
-
40
-
-
84928549786
-
A guide for clinicians in the evaluation of emerging molecular diagnostics for newly diagnosed prostate cancer
-
Canfield SE, Kibel AS, Kemeter MJ, et al. A guide for clinicians in the evaluation of emerging molecular diagnostics for newly diagnosed prostate cancer. Rev Urol 2014; 16:172-180.
-
(2014)
Rev Urol
, vol.16
, pp. 172-180
-
-
Canfield, S.E.1
Kibel, A.S.2
Kemeter, M.J.3
-
41
-
-
46449132555
-
[-2]proenzyme prostate specific antigen for prostate cancer detection: A national cancer institute early detection research network validation study
-
Sokoll LJ, Wang Y, Feng Z, et al. [-2]proenzyme prostate specific antigen for prostate cancer detection: A national cancer institute early detection research network validation study. J Urol 2008; 180:539-543.
-
(2008)
J Urol
, vol.180
, pp. 539-543
-
-
Sokoll, L.J.1
Wang, Y.2
Feng, Z.3
-
42
-
-
79952336412
-
ProPSA and diagnostic biopsy tissue DNA content combination improves accuracy to predict need for prostate cancer treatment among men enrolled in an active surveillance program
-
Isharwal S, Makarov DV, Sokoll LJ, et al. ProPSA and diagnostic biopsy tissue DNA content combination improves accuracy to predict need for prostate cancer treatment among men enrolled in an active surveillance program. Urology 2011; 77:763e1-7636e.
-
(2011)
Urology
, vol.77
, pp. 763e1-7636e
-
-
Isharwal, S.1
Makarov, D.V.2
Sokoll, L.J.3
-
43
-
-
0033429470
-
DD3: A new prostate-specific gene, highly overexpressed in prostate cancer
-
Bussemakers MJG, Van Bokhoven A, Verhaegh GW, et al. DD3: A new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res 1999; 59:5975-5979.
-
(1999)
Cancer Res
, vol.59
, pp. 5975-5979
-
-
Bussemakers, M.J.G.1
Van Bokhoven, A.2
Verhaegh, G.W.3
-
44
-
-
80053315206
-
Contemporary role of prostate cancer antigen 3 in the management of prostate cancer
-
Auprich M, Bjartell A, Chun FKH, et al. Contemporary role of prostate cancer antigen 3 in the management of prostate cancer. Eur Urol 2011; 60:1045-1054.
-
(2011)
Eur Urol
, vol.60
, pp. 1045-1054
-
-
Auprich, M.1
Bjartell, A.2
Chun, F.K.H.3
-
45
-
-
73749086977
-
Accuracy of PCA3 measurement in predicting short-term biopsy progression in an active surveillance program
-
Tosoian JJ, Loeb S, Kettermann A, et al. Accuracy of PCA3 measurement in predicting short-term biopsy progression in an active surveillance program. J Urol 2010; 183:534-538.
-
(2010)
J Urol
, vol.183
, pp. 534-538
-
-
Tosoian, J.J.1
Loeb, S.2
Kettermann, A.3
-
46
-
-
78650250585
-
Critical assessment of preoperative urinary prostate cancer antigen 3 on the accuracy of prostate cancer staging
-
Auprich M, Chun FKH, Ward JF, et al. Critical assessment of preoperative urinary prostate cancer antigen 3 on the accuracy of prostate cancer staging. Eur Urol 2011; 59:96-105.
-
(2011)
Eur Urol
, vol.59
, pp. 96-105
-
-
Auprich, M.1
Chun, F.K.H.2
Ward, J.F.3
-
47
-
-
84898538811
-
Circulating biomarkers for discriminating indolent from aggressive disease in prostate cancer active surveillance
-
Trock BJ. Circulating biomarkers for discriminating indolent from aggressive disease in prostate cancer active surveillance. CurrOpin Urol 2014; 24:293-302.
-
(2014)
CurrOpin Urol
, vol.24
, pp. 293-302
-
-
Trock, B.J.1
-
48
-
-
84907578628
-
ERG protein expression in diagnostic specimens is associated with increased risk of progression during active surveillance for prostate cancer
-
Berg KD, Vainer B, Thomsen FB, et al. ERG protein expression in diagnostic specimens is associated with increased risk of progression during active surveillance for prostate cancer. Eur Urol 2014.
-
Eur Urol 2014
-
-
Berg, K.D.1
Vainer, B.2
Thomsen, F.B.3
-
50
-
-
84905922873
-
A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling
-
Klein EA, Cooperberg MR, Magi-Galluzzi C, et al. A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling. Eur Urol 2014; 66:550-560.
-
(2014)
Eur Urol
, vol.66
, pp. 550-560
-
-
Klein, E.A.1
Cooperberg, M.R.2
Magi-Galluzzi, C.3
-
51
-
-
84862777506
-
Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort
-
Cuzick J, Berney DM, Fisher G, et al. Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort. Br J Cancer 2012; 106:1095-1099.
-
(2012)
Br J Cancer
, vol.106
, pp. 1095-1099
-
-
Cuzick, J.1
Berney, D.M.2
Fisher, G.3
-
52
-
-
79952042778
-
Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: A retrospective study
-
Cuzick J, Swanson GP, Fisher G, et al. Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: A retrospective study. Lancet Oncol 2011; 12:245-255.
-
(2011)
Lancet Oncol
, vol.12
, pp. 245-255
-
-
Cuzick, J.1
Swanson, G.P.2
Fisher, G.3
-
53
-
-
84876080452
-
Validation of a cell-cycle progression gene panel to improve risk stratification in a contemporary prostatectomy cohort
-
Cooperberg MR, Simko JP, Cowan JE, et al. Validation of a cell-cycle progression gene panel to improve risk stratification in a contemporary prostatectomy cohort. J Clin Oncol 2013; 31:1428-1434.
-
(2013)
J Clin Oncol
, vol.31
, pp. 1428-1434
-
-
Cooperberg, M.R.1
Simko, J.P.2
Cowan, J.E.3
|